Inside the drug industry’s plan to defeat the DEA
Newly unsealed documents in a landmark civil case in Cleveland provide clues to one of the most enduring mysteries of the opioid epidemic: How were drug companies able to weaken the federal government’s most powerful enforcement weapon at the height of the crisis? The industry enlisted members of Congress to limit the powers of the …
Continue reading “Inside the drug industry’s plan to defeat the DEA”